Statement Of Income

Fuji Pharma Co.,Ltd. - Filing #7264782

Concept 2024-10-01 to
2025-03-31
2023-10-01 to
2024-03-31
Statement of income
Statement of income
Net sales
24,095,000,000 JPY
21,388,000,000 JPY
Net sales
Operating revenue
Operating expenses
Cost of sales
Cost of sales
14,205,000,000 JPY
13,154,000,000 JPY
Selling, general and administrative expenses
7,584,000,000 JPY
6,789,000,000 JPY
Operating expenses
Research and development expenses
1,363,000,000 JPY
1,726,000,000 JPY
Operating profit (loss)
2,305,000,000 JPY
1,443,000,000 JPY
Gross profit (loss)
9,889,000,000 JPY
8,233,000,000 JPY
Ordinary profit (loss)
2,209,000,000 JPY
2,165,000,000 JPY
Non-operating income
Interest income
3,000,000 JPY
2,000,000 JPY
Gross profit
Extraordinary income
JPY
3,953,000,000 JPY
Non-operating income
Non-operating income
115,000,000 JPY
817,000,000 JPY
Financial revenue
Other
26,000,000 JPY
15,000,000 JPY
Non-operating expenses
Interest expenses
142,000,000 JPY
83,000,000 JPY
Selling, general and administrative expenses
Non-operating expenses
Extraordinary losses
458,000,000 JPY
91,000,000 JPY
Impairment losses
394,000,000 JPY
JPY
Non-operating expenses
Non-operating expenses
210,000,000 JPY
95,000,000 JPY
Financial expenses
Other
32,000,000 JPY
9,000,000 JPY
Extraordinary income
Gain on sale of investment securities
JPY
3,118,000,000 JPY
Profit (loss) before income taxes
1,751,000,000 JPY
6,027,000,000 JPY
Income taxes - current
372,000,000 JPY
1,432,000,000 JPY
Extraordinary losses
Loss on disaster
3,000,000 JPY
30,000,000 JPY
Income taxes - deferred
91,000,000 JPY
337,000,000 JPY
Income taxes
464,000,000 JPY
1,770,000,000 JPY
Profit (loss)
1,287,000,000 JPY
4,257,000,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.